• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

bioRxiv [Preprint]. Outcome of H5N1 clade 2.3.4.4b virus infection in calves and lactating cows

tetano

Editor, Senior Moderator
bioRxiv


[Preprint]. 2024 Aug 9:2024.08.09.607272.
doi: 10.1101/2024.08.09.607272.
Outcome of H5N1 clade 2.3.4.4b virus infection in calves and lactating cows

Nico Joel Halwe, Konner Cool, Angele Breithaupt, Jacob Schön, Jessie D Trujillo, Mohammed Nooruzzaman, Taeyong Kwon, Ann Kathrin Ahrens, Tobias Britzke, Chester D McDowell, Ronja Piesche, Gagandeep Singh, Vinicius Pinho Dos Reis, Sujan Kafle, Anne Pohlmann, Natasha N Gaudreault, Björn Corleis, Franco Matias Ferreyra, Mariano Carossino, Udeni B R Balasuriya, Lisa Hensley, Igor Morozov, Lina M Covaleda, Diego Diel, Lorenz Ulrich, Donata Hoffmann, Martin Beer, Juergen A Richt
Abstract

In March 2024, highly pathogenic avian influenza virus (HPAIV) clade 2.3.4.4b H5N1 infections in dairy cows were first reported from Texas, USA. Rapid dissemination to more than 190 farms in 13 states followed. Here, we provide results of two independent clade 2.3.4.4b experimental infection studies evaluating (i) oronasal susceptibility and transmission in calves to a US H5N1 bovine isolate genotype B3.13 (H5N1 B3.13) and (ii) susceptibility of lactating cows following direct mammary gland inoculation of either H5N1 B3.13 or a current EU H5N1 wild bird isolate genotype euDG (H5N1 euDG). Inoculation of the calves resulted in moderate nasal replication and shedding with no severe clinical signs or transmission to sentinel calves. In dairy cows, infection resulted in no nasal shedding, but severe acute mammary gland infection with necrotizing mastitis and high fever was observed for both H5N1 genotypes/strains. Milk production was rapidly and drastically reduced and the physical condition of the cows was severely compromised. Virus titers in milk rapidly peaked at 10 [SUP]8[/SUP] TCID [SUB]50[/SUB] /mL, but systemic infection did not ensue. Notably, adaptive mutation PB2 E627K emerged after intramammary replication of H5N1 euDG. Our data suggest that in addition to H5N1 B3.13, other HPAIV H5N1 strains have the potential to replicate in the udder of cows and that milk and milking procedures, rather than respiratory spread, are likely the primary routes of H5N1 transmission between cattle.





 
Back
Top Bottom